Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT138712141743N1
IRCT138712141743N1
Completed
未知

Memantine add on to treatment of refractory obssessive compulsive disorder

Research Center for Behavioral Disorder and Substance Abuse, Hamadan University of Medical Sciences0 sites72 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsObsessive- Cumpulsive Disorder.Obsessive-compulsive disorder

Overview

Phase
未知
Status
Completed
Sponsor
Research Center for Behavioral Disorder and Substance Abuse, Hamadan University of Medical Sciences
Enrollment
72
OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
no limit to no limit (—)
Sex
All

Inclusion Criteria

  • •Suffering from OCD, taking a therapeutic dose of a SSRI or Clomipramine, at least for 12 weeks, Y\_BOSC score of 16 or greater Exclusion criteria: primary diagnosis of psychosis or bipolar mood disorder, substance abuse or dependency, uncontrolled medical condition, having had a pervious trial of Memantine, pregnancy or breast feeding, rising liver enzymes to more than twice of normal range during intervention, presence of MDD

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Research Center for Behavioral Disorder and Substance Abuse, Hamadan University of Medical Sciences

Similar Trials

Completed
Phase 2
Memantine in the treatment of obsessive-compulsive disorder
IRCT201106031556N22Tehran University of Medical Sciences40
Active, not recruiting
Phase 1
Pharmacological treatment with memantine of oscilloscopy in patients suffering from multiple sclerosis: randomized,double blind placebo controlled study. - NDmultiple sclerosisMedDRA version: 9.1Level: LLTClassification code 10028053Term: MS
EUCTR2008-000490-37-ITOSPEDALE S. RAFFAELE40
Completed
Phase 3
se of memantin in treatment of adult with attention deficit hyperactivity disorderAdult ADHD (Attention-deficit hyperactivity disorder ).Disturbance of activity and attention
IRCT2016053028182N1Kurdistan University of Medical science40
Completed
Phase 3
adding memantine to treatment of schozopherenia
IRCT20180301038906N1Mashhad University of Medical Sciences60
Recruiting
Not Applicable
Memantine for treatment of Obsessive-Compulsive Disorder
IRCT20170123032145N4Iran University of Medical Sciences44